Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined With Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE)Clin. Cancer Res 2021 Jan 20;[EPub Ahead of Print], SJ Crabb, S Danson, JWF Catto, S Hussain, D Chan, D Dunkley, N Downs, E Marwood, L Day, GN Saunders, M Light, A Whitehead, DJ Ellis, N Sarwar, D Enting, AJ Birtle, B Johnson, R Huddart, G Griffiths
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.